What is the recommended dosage of mefenamic acid for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mefenamic Acid Dosage for Pediatrics

Recommended Dosing

For pediatric patients, mefenamic acid is dosed at 6 mg/kg per dose, with a typical dosing interval of every 6-8 hours as needed for pain or fever. 1

Evidence-Based Dosing Details

  • Standard pediatric dose: 6 mg/kg per dose 1
  • This dosing has been validated in clinical trials comparing mefenamic acid to paracetamol for antipyretic effects in febrile children 1
  • The medication demonstrated effective and rapid antipyretic action at this dose, with temperature normalization occurring in approximately 85 minutes on average 1
  • Duration of antipyretic effect lasted approximately 8-9 hours before the next fever spike 1

Clinical Considerations

Safety Profile

  • Mefenamic acid at 6 mg/kg showed negligible adverse effects in pediatric studies 1
  • However, as an NSAID, it should be reserved for pain management or chronic inflammatory conditions rather than routine fever treatment 1

When to Use vs. Alternatives

  • High-dose paracetamol (20 mg/kg) provides equivalent antipyretic efficacy to mefenamic acid with a similar safety profile 1
  • Consider paracetamol as first-line for simple fever management, reserving mefenamic acid for pain or inflammatory indications 1
  • Standard-dose paracetamol (15 mg/kg) has slower onset and shorter duration compared to both high-dose paracetamol and mefenamic acid 1

Important Caveats

  • Pediatric dosing cannot be simply scaled down from adult doses using weight alone, as this results in inappropriate dosing in different age groups 2
  • Children under 2 years require special consideration due to immature drug elimination pathways 2
  • Always verify that mefenamic acid is approved for pediatric use in your specific jurisdiction, as availability varies by country 3

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.